UNLIMITED TURBO BULL - AMGEN | Real-time Euronext Paris 10:34:42 2024-06-10 EDT | ||
| 11.11 EUR | -3.22% |
|
| Current month | +2.32% | ||
| 1 month | +5.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-10 | 11.11 | -3.22% |
| 24-06-07 | 11.48 | -0.69% |
| 24-06-06 | 11.56 | -0.52% |
| 24-06-05 | 11.62 | +0.43% |
| 24-06-04 | 11.57 | +2.21% |
Real-time Euronext Paris
Last update June 10, 2024 at 10:34 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| 8C37S | |
| ISIN | DE000SU96G03 |
| Date issued | 2024-03-04 |
| Strike | 183.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.79 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.62 € |
|---|---|
| Lowest since issue | 7.5 € |
| Spread | 0.03 € |
| Spread % | 0.27% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Certificates
- 8C37S Certificat
